Quest Diagnostics (DGX)
Quest Diagnostics Statistics
Share Statistics
Quest Diagnostics has 111.61M shares outstanding. The number of shares has increased by -0.1% in one year.
| Shares Outstanding | 111.61M |
| Shares Change (YoY) | -0.1% |
| Shares Change (QoQ) | -0.57% |
| Owned by Institutions (%) | 89.04% |
| Shares Floating | 111.03M |
| Failed to Deliver (FTD) Shares | 389 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 2.86M, so 2.58% of the outstanding shares have been sold short.
| Short Interest | 2.86M |
| Short % of Shares Out | 2.58% |
| Short % of Float | 2.94% |
| Short Ratio (days to cover) | 2.58 |
Valuation Ratios
The PE ratio is 19.23 and the forward PE ratio is 15.56. Quest Diagnostics's PEG ratio is 6.95.
| PE Ratio | 19.23 |
| Forward PE | 15.56 |
| PS Ratio | 1.7 |
| Forward PS | 1.5 |
| PB Ratio | 2.47 |
| P/FCF Ratio | 18.42 |
| PEG Ratio | 6.95 |
Enterprise Valuation
Quest Diagnostics has an Enterprise Value (EV) of 23.12B.
| EV / Sales | 2.34 |
| EV / EBITDA | 12.11 |
| EV / EBIT | 17.33 |
| EV / FCF | 25.44 |
Financial Position
The company has a current ratio of 1.1, with a Debt / Equity ratio of 1.02.
| Current Ratio | 1.1 |
| Quick Ratio | 1.02 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 3.63 |
| Debt / FCF | 7.62 |
| Interest Coverage | 5.96 |
Financial Efficiency
Return on Equity is 12.85% and Return on Invested Capital is 7%.
| Return on Equity | 12.85% |
| Return on Assets | 5.39% |
| Return on Invested Capital | 7% |
| Revenue Per Employee | $219.38K |
| Profits Per Employee | $19.36K |
| Employee Count | 45,000 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 35.26 |
Taxes
| Income Tax | 273M |
| Effective Tax Rate | 23.23% |
Stock Price Statistics
The stock price has increased by 30.12% in the last 52 weeks. The beta is 0.78, so Quest Diagnostics's price volatility has been higher than the market average.
| Beta | 0.78 |
| 52-Week Price Change | 30.12% |
| 50-Day Moving Average | 168.63 |
| 200-Day Moving Average | 156.92 |
| Relative Strength Index (RSI) | 44.81 |
| Average Volume (20 Days) | 1.31M |
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 9.87B and earned 871M in profits. Earnings per share was 7.8.
| Revenue | 9.87B |
| Gross Profit | 3.24B |
| Operating Income | 1.35B |
| Net Income | 871M |
| EBITDA | 1.91B |
| EBIT | 1.4B |
| Earnings Per Share (EPS) | 7.8 |
Balance Sheet
The company has 549M in cash and 6.92B in debt, giving a net cash position of -6.38B.
| Cash & Cash Equivalents | 549M |
| Total Debt | 6.92B |
| Net Cash | -6.38B |
| Retained Earnings | 9.36B |
| Total Assets | 16.15B |
| Working Capital | 223M |
Cash Flow
In the last 12 months, operating cash flow was 1.33B and capital expenditures -425M, giving a free cash flow of 909M.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -425M |
| Free Cash Flow | 909M |
| FCF Per Share | 8.19 |
Margins
Gross margin is 32.86%, with operating and profit margins of 13.63% and 8.82%.
| Gross Margin | 32.86% |
| Operating Margin | 13.63% |
| Pretax Margin | 11.9% |
| Profit Margin | 8.82% |
| EBITDA Margin | 19.34% |
| EBIT Margin | 13.63% |
| FCF Margin | 9.21% |
Dividends & Yields
DGX pays an annual dividend of $3.8, which amounts to a dividend yield of 1.86%.
| Dividend Per Share | $3.80 |
| Dividend Yield | 1.86% |
| Dividend Growth (YoY) | 5.63% |
| Payout Ratio | 49.41% |
| Earnings Yield | 5.2% |
| FCF Yield | 5.43% |
Analyst Forecast
The average price target for DGX is $181, which is 10.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $181 |
| Price Target Difference | 10.5% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Jun 21, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 21, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 6 |